Scientists at the National Taiwan University Cancer Center and National Taiwan University Hospital have shed light on rare ...

In a TNBC animal model with limited responsiveness to chemotherapy, Telomir-1 demonstrated statistically significant activity on both tumor growth and cancer cell spread.

Pancreatic cancer may evade the immune system using a clever molecular trick. Researchers found that the cancer-driving ...

A joint team of Chinese and US researchers has identified a specific group of highly adaptable tumor cells that act as a “central hub” driving lung cancer ...

Scientists from A*STAR Institute of Molecular and Cell Biology (A*STAR IMCB) have identified why certain lung cancer cells ...

When lung cancer treatment stops working, what happens next? New research reveals the answer may depend on how the cancer ...

Could this mark a shift in how we think about cancer therapy? At least in the laboratory, evidence suggests it may be . An ...

Prostate cancer is the second-most common cancer in men. A new study from Thomas Jefferson University uncovered a new ...

MYC‑driven tumors silence innate immune alarms by clearing R‑loop–derived signals, exposing a new therapeutic angle for targeting MYC without broad inhibition.

Scientists have described a novel, yet benign bone-covered growth's characteristics for doctors, so patients don't receive ...

A newly uncovered immune chain reaction in the gut may explain why people with inflammatory bowel disease face a much higher ...

As we get older, chemical marks on our DNA slowly shift. Now, a study reveals this 'drift' in gut stem cells is fueled by ...